-
Innovation Ranking
NewInnovation Ranking – BrightGene Bio-Medical Technology Co Ltd
BrightGene Bio-Medical Technology Co Ltd (BrightGene) is a biopharmaceutical company that manufacturing, research and develop of generic drugs. The company’s pipeline products include posaconazole, oseltamivir phosphate, orivancin, fidaxomycin, agatroban, fondaparinux, acarbose, iron supplements, trabectidine, pemetrexed disodium intermediate, eribulin mesylate, midotolin, everolimus and pimecrolimus, among others. Its veterinary drugs includes seramectin, telavancin hydrochloride, emodes, doramectin and dalbavancin. The company develops products in the therapeutic areas of cardiology, oncology, antibacterial, antifungal and veterinary. BrightGene is headquartered in Suzhou, Jiangsu, China.
-
Innovation Ranking
NewInnovation Ranking – Shenzhen Mindray Bio-Medical Electronics Co Ltd
Shenzhen Mindray Bio-Medical Electronics Co Ltd (Mindray) develops, manufactures and markets medical devices and solutions. The company offers in-vitro diagnostics, products for patient monitoring and life support, orthopedics, veterinary, and medical imaging systems, among others. Its major products include patient monitoring systems, anesthesia machines, ventilators, electrocardiographs, defibrillators, surgical lights, operating tables, medical supply units, infusion pumps endoscopes, and accessories. Mindray also offers a chemistry analyzer and reagents, flow cytometry, and mobile and digital radiography systems. The company serves hospitals, medical...
-
Company Insights
Innovation and Patenting activity of Shenzhen Mindray Bio-Medical Electronics Co Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Shenzhen Mindray Bio-Medical Electronics Co Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The...
-
Sector Analysis
NewImmunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of more than 4% during 2023-2033. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. They are typically offered in modular increments, which can operate independently or simultaneously as a unit. Immunochemistry Analyzers Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into...
-
Sector Analysis
NewPCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
PCR Systems Market Report Overview The PCR Systems market size was $700.3 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Polymerase Chain Reaction (PCR) systems are used to perform nucleic acid amplification, typically in support of investigations concerning the diagnosis or prognosis of cancer or infectious disease. PCR Systems Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the PCR Systems Market Forecast Download a Free...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Genistein in Pulmonary Radiation Toxicity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Genistein in Pulmonary Radiation Toxicity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genistein in Pulmonary Radiation Toxicity Drug Details: Genistein (BIO-300) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Genistein in Non-Small Cell Lung Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Genistein in Non-Small Cell Lung Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Genistein in Non-Small Cell Lung Carcinoma Drug Details: Genistein (BIO-300)...
-
Product Insights
NewBreast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Breast Implants Pipeline Market Report Overview Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments...
-
Product Insights
Artificial Pancreas Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Artificial Pancreas Pipeline Market Report Overview The artificial pancreas aids people in controlling their blood glucose level or diabetes, primarily type 1, automatically by continuously providing the substitute endocrine functionality of a healthy pancreas. The artificial pancreas pipeline market research report provides comprehensive information about the products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise artificial pancreas clinical trials outlook. The regulatory paths followed for conducting the artificial pancreas pipeline...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...